Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T54931
|
||||
Former ID |
TTDR00195
|
||||
Target Name |
Nicotinic acetylcholine receptoralpha2 / alpha3
|
||||
Target Type |
Research
|
||||
Disease | Drug abuse [ICD9: 303-304; ICD10: F10-F19] | ||||
UniProt ID | |||||
Antagonist | 18-Methoxycoronaridine | Drug Info | [1] | ||
Ibogaine | Drug Info | [1] | |||
Laudanosine | Drug Info | [2] | |||
Volatile anesthetics | Drug Info | [3] | |||
Agonist | SIB-1533A | Drug Info | [4] | ||
References | |||||
REF 1 | Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur J Pharmacol. 2002 Mar 1;438(1-2):99-105. | ||||
REF 2 | Blockade and activation of the human neuronal nicotinic acetylcholine receptors by atracurium and laudanosine. Anesthesiology. 2001 Apr;94(4):643-51. | ||||
REF 3 | The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res Bull. 2002 Jan 15;57(2):133-50. | ||||
REF 4 | Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Arch Med Res. 2000 Mar-Apr;31(2):131-44. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.